Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939 - an oral, direct Factor Xa inhibitor - after multiple dosing in healthy male subjects - Kubitza, D; Becka, M; Wensing, G (Eur J Clin Pharmacol, 2005)
et al.